Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Consultant & Investment Group's revenue per share for the
three
months ended in Jun. 2026 was JOD0.29.
The Consultant & Investment Group's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was JOD1.20.
Warning Sign:
The Consultant & Investment Group revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of The Consultant & Investment Group was -0.70% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 9.80% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.50% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 6.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for The Consultant & Investment Group's Revenue per Share or its related term are showing as below:
AMM:CICO'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -14.9 Med: 9 Max: 34.4
Current: 9.8
During the past 13 years, The Consultant & Investment Group's highest 3-Year average Revenue Per Share Growth Rate was 34.40% per year. The lowest was -14.90% per year. And the median was 9.00% per year.
AMM:CICO's 3-Year Revenue Growth Rate is ranked better than 60.29% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 6.95
vs AMM:CICO: 9.80
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
The Consultant & Investment Group Revenue per Share Related Terms
The Consultant & Investment Group Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group Revenue per Share Chart
AMM:CICO vs HCA, THC, DVA: Revenue per Share Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's PS Ratio falls into.
The Consultant & Investment Group Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD1.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group (AMM:CICO) has a Revenue per Share of JOD1.20 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on The Consultant & Investment Group and its competitors. According to the industry distribution chart, The Consultant & Investment Group ranks #243 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 39.7%.
Is The Consultant & Investment Group's Revenue per Share too high?
The Consultant & Investment Group's current Revenue per Share is JOD1.20. Based on the distribution chart, The Consultant & Investment Group ranks #243 out of 612 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Consultant & Investment Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's Revenue per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #243 out of 612 companies for Revenue per Share. This puts The Consultant & Investment Group in the upper half of its industry. The industry median Revenue per Share is 6.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 6.95, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on The Consultant & Investment Group and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 6.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current Revenue per Share is JOD1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.05, compared to a current price of JOD1.78 — trading 13.2% below its estimated fair value. The current Revenue per Share is JOD1.20. The Consultant & Investment Group's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current Revenue per Share is JOD1.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 13.2% below its estimated GF Value™ of JOD2.05.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
Revenue per Share: JOD1.20
GF Value™: JOD2.05 vs. price of JOD1.78 (13.2% below fair value)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
73GF Score
Get the complete analysis for AMM:CICO
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 
